SWTX Multiplikator Forward P/S SpringWorks Therapeutics, Inc.

The projected P/S metric clearly captures investor sentiment swings, with the parameter value standing at 16.00. SpringWorks Therapeutics (SWTX) remains completely insulated from economic downturns due to the high value of its oncology drugs. Demand for specialized treatment is independent of macroeconomic indicators, relying instead on clinical success. Patent protection secures the company's pioneer status, eliminating pressure from low-cost generics.

SWTX (springworkstx.com) riwayat Rasio rega marang pendapatan sing dikarepake saka 01.03.2024 nganti 12.07.2025

SpringWorks Therapeutics, Inc - rincian analitis lan metrik utama (SWTX)

- rega saiki lan proyeksi nilai saham:

Rega saham SpringWorks Therapeutics, Inc.|SWTX - Rentang target analis

- data kapitalisasi pasar:

Kapitalisasi pasar SpringWorks Therapeutics, Inc|SWTX - Total Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi saben Saham SpringWorks Therapeutics|SWTX - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku springworkstx.com|SWTX - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal SpringWorks Therapeutics|SWTX - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas SpringWorks Therapeutics|SWTX - Kewajiban utang agregat|Utang marang nilai buku SpringWorks Therapeutics, Inc|SWTX - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan SpringWorks Therapeutics|Rasio cepet springworkstx.com

- indikator pendapatan resik lan kelipatan nilai:

SWTX - Penghasilan resik perusahaan|Bathi sing dikarepake SpringWorks Therapeutics|SWTX - Nilai perusahaan marang bathi resik|Pangali Forward P/E SpringWorks|SWTX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SpringWorks Therapeutics, Inc|SWTX - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan SpringWorks Therapeutics|SWTX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan springworkstx.com|SWTX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SpringWorks Therapeutics

- rincian pendapatan lan dodolan emiten:

SWTX - Pendapatan tahunan perusahaan|Prakiraan pendapatan perusahaan SpringWorks Therapeutics, Inc.|SWTX - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S SpringWorks Therapeutics, Inc

Ringkesan analisis perusahaan:SpringWorks Therapeutics, Inc. (SWTX)

The market assesses the investment potential of SpringWorks Therapeutics (SWTX) through the lens of expected revenue, where the current value of 16.00 reflects the cost of one dollar of future sales. By analyzing the forward P/S history, an investor can see how the full utilization of partner capacities for oncology drug production converts into the market value of this high-risk biopharmaceutical asset.

Perusahaan pesaing

Multiplikator Forward P/S GMAB (Genmab)|Prakiraan rega marang pendapatan Exelixis Inc|Nuvalent Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Kymera Corp|IDYA (IDEAYA Biosciences) - Multiplikator forward rega marang pendapatan|ELVN: Rasio rega marang pendapatan sing dikarepake|ORIC (ORIC Pharmaceuticals, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Relay Therapeutics Inc RLAY|Multiplikator Forward P/S NRIX|Tyra Corp - Kapitalisasi marang prakiraan pendapatan|Verastem, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan GLUE|CGEM: Multiplikator forward rega marang pendapatan|Immuneering Corp - Rasio rega marang pendapatan sing dikarepake|CCCC: Multiplikator Forward P/S|Black Diamond Therapeutics, Inc - Rega forward marang dodolan|RPTX (Repare Therapeutics) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep pmvpharma.com PMVP|Rasio rega marang prakiraan pendapatan Karyopharm Therapeutics (KPTI)|PPCB (propanc.com) - Rega forward marang dodolan|Multiplikator Forward P/S BGMS (Cyclacel Pharmaceuticals)|Multiplikator Forward P/S Aadi Bioscience Inc AADI|ALRN - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan BPMC|GLYC (glycomimetics.com) - Multiplikator forward rega marang pendapatan